- Home
- PRTA vs ODV Comparison
PRTA vs ODV Comparison
Compare PRTA & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | ODV |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Ireland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 844.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRTA | ODV |
|---|---|---|
| Price | $10.73 | $3.57 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.86 | N/A |
| AVG Volume (30 Days) | 602.7K | ★ 1.2M |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,786,000.00 | $8,089,655.00 |
| Revenue This Year | N/A | $102.54 |
| Revenue Next Year | $819.08 | $106.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $1.16 |
| 52 Week High | $17.66 | $3.89 |
Technical Indicators
Market Signals| Indicator | PRTA | ODV |
|---|---|---|
| Relative Strength Index (RSI) | 55.81 | 58.69 |
| Support Level | $10.14 | $3.38 |
| Resistance Level | $11.57 | $3.60 |
| Average True Range (ATR) | 0.57 | 0.15 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 56.59 | 84.73 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.